Dosage: 150 mg
Specification: 224 tabs per box
Manufacturer: Genentech Roche
Alecensa is a kinase inhibitor for the treatment of patients with anaplastic lymphoma kinase (ALK) -positive, metastatic non-small cell lung cancer (NSCLC) who have progressed or are resistant to xolatinib. This indication is approved under accelerated approval according to tumor response rate and response time. Continued approval of this indication may depend on the validation and description of clinical benefits in a confirmatory trial.
We provide customers with quality products and services.
If you would like to leave us a comment please go to contact us